Alopecia Areata: An Update

    K A Seetharam
    Image of study
    TLDR The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.
    The 2013 document provides a comprehensive update on alopecia areata (AA), detailing its etiology, clinical presentation, diagnosis, and treatment options. AA is identified as an autoimmune condition with genetic predisposition and potential environmental triggers. It affects both genders equally and is most prevalent between ages 30-59. Diagnosis is aided by scalp biopsies and dermoscopy, while the SALT score helps assess severity. Spontaneous hair regrowth is common, but prognosis worsens with factors like early onset and associated autoimmune diseases. Treatments include corticosteroids, minoxidil, anthralin, immunotherapy, and phototherapy, but a Cochrane review highlights the lack of definitive cures. Topical immunotherapy with DPCP and phototherapy show variable success, and while some new treatments are under investigation, corticosteroids remain the primary therapy. The document underscores the need for controlled studies to establish effective treatments for AA.
    Discuss this study in the Community →

    Cited in this study

    4 / 4 results

    Related

    4 / 4 results